Replies to post #357475 on Amarin Corp Plc (AMRN)

[alm2]

Capt

Brilliant !!

Send it on to Amarins lawyers least they forget this major point of infringement
Alm

[Number sleven]

Captain, That is what FDA requires. In the thinking of FDA the generic companies can't put the CVD disclaimer on the label. FDA rated the product an A/B equivalent. As far as FDA is concerned the two products are the same. FDA has no concerns about the little stuff.(like patent law)
Sleven,

[lizzy241]

capt, my favorite pages are 67 & 68.

The Court: But if what you're approved for is severe hypertriglyceridemia or whatever it is :-), why don't you just say that rather than hyperglycemia? :-)
Mr. Klein "I don't know why" LOL

[sstyles]

Excellent point.

[rdhitchcock]

Capt....definitely agree with you there. To the best of my knowledge there is no data showing that icosapent ethyl reduces cardiovascular events in patients with trigs >500. Should still be on their label for their intended indication.